> News > Biopôle SA and IMA MED-TECH sign a corporate partnership agreement, strengthening our innovation ecosystem with industrialisation expertise
13.10
2026

Biopôle SA and IMA MED-TECH sign a corporate partnership agreement, strengthening our innovation ecosystem with industrialisation expertise

Biopôle is pleased to announce a new corporate partnership with IMA MED-TECH, effective immediately.

The agreement marks a significant step for the Biopôle community. The partnership also gives IMA MED-TECH visibility into Biopôle’s pipeline of innovative companies, while providing companies on campus with access to IMA MED-TECH’s expertise in supporting the transition of prototypes from the lab towards industrialisation.

Leveraging more than six decades of IMA’s industrial expertise, IMA MED-TECH, the business unit of IMA AUTOMATION dedicated to medical assembly technologies, has become a global leader in advanced automation solutions for the processing and assembly of medical devices and pharmaceutical delivery systems. It creates solutions tailored to customer needs, using advanced mechatronic and digital technologies. The group aims to design advanced solutions that create value for both customers and society, guided by a desire to shape smarter, more sustainable manufacturing worldwide.

As a corporate partner, IMA MED-TECH will be part of the Biopôle life sciences community, with access to our innovation pipeline, business intelligence and premium infrastructure.

“We are proud to partner with Biopôle SA and become part of one of Europe’s leading life sciences ecosystems. This collaboration provides IMA MED-TECH with access to a dynamic network that supports our strategic growth in biotechnology, with a focus on diagnostic and laboratory applications, cell and gene therapies, and advanced life science solutions,” said Stephane Vuilleumier, CEO of the IMA MEDTECH Business Sector. “Beyond business opportunities, this partnership fosters collaboration and innovation, creating new synergies for the development of next-generation medical devices and healthcare technologies. We are confident that joining the Biopôle ecosystem will accelerate our innovation journey while further strengthening IMA MED-TECH’s long-standing presence in the Neuchâtel region,” he added.

Nasri Nahas, CEO of Biopôle SA commented: “Sitting at the intersection of MedTech and automation, IMA MED-TECH brings valuable hands-on expertise in taking projects from early development through to industrialisation and high-volume production. We’re excited to make this expertise available to companies across the Biopôle ecosystem, helping them bring innovative solutions from the lab closer to market. At the same time, the partnership opens the door for IMA MED-TECH to connect with new technologies, ideas and opportunities for collaboration.”

To learn more about IMA MED-TECH, please visit the IMA website.

 

Learn more about the Corporate Partnerships Programme